Rituximab causes a polarization of B cells that augments its therapeutic function in NK-cell-mediated antibody-dependent cellular cytotoxicity. (2013)

First Author: Rudnicka D

Attributed to: Drug Delivery at the Immunological Synapse funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood-2013-02-482570

PubMed Identifier: 23613524

Publication URI: http://europepmc.org/abstract/MED/23613524

Type: Journal Article/Review

Volume: 121

Parent Publication: Blood

Issue: 23

ISSN: 0006-4971